NEB-001 Intelligent Mesh Nebulizer FDA Mesh Portable Nebulizer

NEB-001 FDA approved Intelligent Mesh Nebulizer

NEB-001 FDA approved Intelligent Mesh Nebulizer

world’s first mobile game guided mesh nebulizer approved by FDA

Feature

1. Small and portable,Only 100g,lighter than a smart phone.

2. Rechargeable and long duration. Built-in rechargable lithium battery provides 4-6 hours’ nebulization.Charging via a a USB port.

3. Whisper quitet, operation noise is less than 50dB,even quieter than whisper.

4. Adjustable strength of atomization via APP,3different levels of atomization rate(High-Middle-Low) are available.

Ultrafine particles for better therapeutic effects

NEB-001 has achieved, that more than 80% of particles during the nebulization treatment are smaller than 5µm, and the MMAD is only 2.2 µm. Medicine can DIRECTLY access at the affected area.

Mobile Game App Guided Atomization via Bluetoot

NEB-001 nebulizer can connect with a game app via Bluetooth, increasing the interest of treatment and enhancing compliance apparently. With rigorous design,the game encourages patients to take deep breath and finally increases the lung deposit of medicine.

Original I.A.D Technology

IAD technology is progressed by a smart respiratory sensor to realize "Respiratory Monitoring", which allows the nebuliz­er to atomize medicine while inhaling, and suspend atomizing while exhaling, reducing the feeling of cough.

Specification

Nebulizer consumable accessories

FAQ

A: Are you factory or a trading company?

Q: We are factory and we have our own R&D and QC team.

A: What certificates do you have? Which markets can you you sell?

Q: We have US FDA,CE certificates. We already sold our products in USA, Latin America,Europe, Asia,Middle East.

A: Can you do the desire and custom work for me?

Q: We can offer both OEM and ODM service according to customers’ request.

Company Profile

Yirdoc is a leading innovator in customized mesh nebulizers for inhalation therapy, offering patented technology and digital solutions to optimize delivery and maximize dose efficiency. Our expertise extends across small molecules and biologics, including LNP-encapsulated mRNA, peptides, antibodies, and exosomes, making us a pivotal partner in the biopharmaceutical industry. With a proven track record in enhancing clinical outcomes and supporting formulation development, Yirdoc delivers tailored solutions that meet the unique needs of our clients. We empower partners to navigate drug delivery complexities, ensuring their therapies achieve optimal results.

Yirdoc has operations in 3 locations and has partnered with a number of leading biopharmaceutical companies across the globe and has exported its products to more than 40 countries, including the USA, EU countries, Australia, South Korea India, Saudi Arabia, and many others.

Our Location